2025
Decongestion in heart failure: medical and device therapies
Cox Z, Damman K, Testani J. Decongestion in heart failure: medical and device therapies. Nature Reviews Cardiology 2025, 1-17. PMID: 40295876, DOI: 10.1038/s41569-025-01152-z.Peer-Reviewed Original ResearchHeart failure symptomsHeart failureDevice therapyFailure symptomsPersistent heart failure symptomsDesign of clinical trialsImplementing novel therapiesHeart failure outcomesMagnitude of benefitImprove decongestionPrimary therapyLoop diureticsResidual congestionNovel therapiesAdverse outcomesClinical trialsTherapyMedical strategiesPredominant causeFailure outcomesHospital readmissionHospitalTargeting congestionDecongestionHeart
2018
Molecular epidemiology of Cryptosporidium spp. in North Lebanon.
Osman M, Benamrouz S, Guyot K, El Safadi D, Mallat H, Dabboussi F, Hamze M, Viscogliosi E, Certad G. Molecular epidemiology of Cryptosporidium spp. in North Lebanon. The Journal Of Infection In Developing Countries 2018, 12: 34s. PMID: 31805009, DOI: 10.3855/jidc.10014.Peer-Reviewed Original ResearchRisk factorsFirst molecular epidemiology studySymptomatic hospitalized patientsIntestinal parasitic infectionsZiehl-Neelsen stainingMain transmission routeCryptosporidium sppMolecular epidemiology studiesGastrointestinal symptomsHospitalized patientsGastrointestinal tractParasitic infectionsEpidemiology studiesNorth LebanonPredominant causeMolecular epidemiologyChild populationFoodborne outbreaksMolecular testsCryptosporidiosisSocio-economic levelEpidemiological situationTransmission routesC. parvumFecal samples
2017
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure Current Status and Prospects for Further Research
Costanzo MR, Ronco C, Abraham WT, Agostoni P, Barasch J, Fonarow GC, Gottlieb SS, Jaski BE, Kazory A, Levin AP, Levin HR, Marenzi G, Mullens W, Negoianu D, Redfield MM, Tang WHW, Testani JM, Voors AA. Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure Current Status and Prospects for Further Research. Journal Of The American College Of Cardiology 2017, 69: 2428-2445. PMID: 28494980, PMCID: PMC5632523, DOI: 10.1016/j.jacc.2017.03.528.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsRenal functionAdverse heart failure outcomesVital signsHeart failure hospitalizationHeart failure outcomesHeart failure eventsLower acuity hospital settingsEffective decongestionExtracorporeal ultrafiltrationCreatinine increaseFailure hospitalizationSerum creatinineStandard carePharmacological therapyMore complicationsPoor outcomeDiuretic agentsPatient's vital signsHospital settingSustained benefitFluid removalPredominant causeFailure outcomesUltrafiltration rateFurther research
2015
Identification of invasive Salmonella enterica serovar Typhimurium ST313 in ambulatory HIV-infected adults in Mozambique
Moon TD, Johnson M, Foster MA, Silva WP, Buene M, Valverde E, Morais L, Williams JV, Vermund SH, Brentlinger PE. Identification of invasive Salmonella enterica serovar Typhimurium ST313 in ambulatory HIV-infected adults in Mozambique. Journal Of Global Infectious Diseases 2015, 7: 139-142. PMID: 26751031, PMCID: PMC4693304, DOI: 10.4103/0974-777x.170496.Peer-Reviewed Original ResearchMultilocus sequence typingAmbulatory HIVINTS diseaseInvasive non-typhoidal salmonella (iNTS) diseaseTyphimurium ST313Non-typhoidal salmonella diseaseS. Typhimurium ST313Multiple sub-Saharan African countriesBlood isolatesSalmonella diseaseMozambican adultsPredominant causeTreatment initiativesTyphimurium ST19Salmonella enterica serovar TyphimuriumST313Vulnerable populationsSequence typingDiseaseEnterica serovar TyphimuriumHIVPositive controlSub-Saharan African countriesSequence typesSaharan Africa
2011
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity
Machado R, Barst R, Yovetich N, Hassell K, Kato G, Gordeuk V, Gibbs J, Little J, Schraufnagel D, Krishnamurti L, Girgis R, Morris C, Rosenzweig E, Badesch D, Lanzkron S, Onyekwere O, Castro O, Sachdev V, Waclawiw M, Woolson R, Goldsmith J, Gladwin M, Investigators and Patients O. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood 2011, 118: 855-864. PMID: 21527519, PMCID: PMC3148167, DOI: 10.1182/blood-2010-09-306167.Peer-Reviewed Original ResearchConceptsTricuspid regurgitation velocitySickle cell diseaseLower exercise capacityExercise capacityCell diseaseN-terminal pro-brain natriuretic peptideElevated tricuspid regurgitation velocityPro-brain natriuretic peptideSerious adverse eventsPulmonary arterial hypertensionSildenafil trialArterial hypertensionAdverse eventsWalk distanceDoppler echocardiographySCD patientsHospitalization ratesNatriuretic peptidePatientsSildenafilPredominant causePainHospitalizationTreatment effectsDisease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply